Group 1: Company Performance - Ollie's Q1 sales reached $576.77 million, a 13% increase from $508.82 million year-over-year, exceeding estimates by 2% [2] - HealthEquity's Q1 sales were $330.84 million, up 15% from $287.6 million in the previous year, surpassing estimates by 3% [3] - Ollie's Q1 earnings per share (EPS) were $0.75, beating expectations of $0.70 by 7% and increasing 3% from the prior period [2] - HealthEquity's Q1 EPS was $0.97, a 21% increase from $0.80 year-over-year, exceeding expectations by nearly 20% [3] Group 2: Strategic Initiatives - Ollie's opened 25 new stores in Q1, marking a record for any period in its history, and has over 500 stores across 32 states [4][5] - The company capitalized on retail store closures and supply chain disruptions to acquire new locations, particularly through bankruptcy auctions of former Big Lots stores [5][7] - HealthEquity's growth was driven by its enrollment and contribution strategy, which focuses on helping employers reduce healthcare costs while empowering employees [8] Group 3: Market Position and Outlook - Ollie's stock has remained virtually flat for the year but has increased over 400% since its IPO in 2015 [7] - HealthEquity's Health Savings Accounts (HSA) assets grew 15% year-over-year to a record $31.27 billion, contributing to a stock rally that reached new 52-week highs [9] - Both companies are expected to achieve double-digit EPS growth in fiscal years 2026 and 2027, making them attractive investment opportunities amid economic uncertainty [13]